Register to vote

Nominated For
12 Votes Share
iX Syrinx Pty Ltd
Xativa® is formulated using WaferiX®, a patented sublingual (under the tongue) delivery technology by iX Biopharma. Each wafer contains a nanoemulsion of highly bioavailable broad spectrum cannabis extract with 12.5mg cannabidiol and 0mg THC, in addition to 30+ terpenes and other beneficial molecules naturally occuring in cannabis.